» Articles » PMID: 15247708

A Referral Center's Experience with Transitional Cell Carcinoma Misdiagnosed As Interstitial Cystitis

Overview
Journal J Urol
Publisher Wolters Kluwer
Specialty Urology
Date 2004 Jul 13
PMID 15247708
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: There has been a recent trend to diagnose interstitial cystitis (IC) in a noninvasive way using a potassium sensitivity test, and a pelvic pain, urgency and frequency questionnaire. The concern is that significant pathology causing the bladder symptoms may be missed, such as transitional cell carcinoma. We present our experience with patients "labeled" as having IC who truly had cancer as the cause of irritative symptoms.

Materials And Methods: A retrospective review of patient records at our IC center was performed from 1998 to 2002. A total of 600 patients were seen at that time with the diagnosis of interstitial cystitis.

Results: Six patients (1%) previously diagnosed as having IC were found to have transitional cell carcinoma as the cause of symptoms, 4 of whom (67%) had no hematuria. Mean time from the diagnosis of IC to diagnosis of transitional cell carcinoma was 29.8 months. Irritative bladder symptoms resolved after identifying and treating the malignancy.

Conclusions: Patients with irritative voiding symptoms require a thorough evaluation which may include cystoscopy, cytology and upper tract imaging. Hematuria was not a good predictor of cancer in our series. In the era before widespread use of minimally invasive means to diagnose IC (ie potassium sensitivity test, pelvic pain, urgency and frequency questionnaire) 1% of patients who were considered to have IC actually had transitional cell cancer as the cause of symptoms. One would expect that this number would increase if the criteria to diagnose IC and initiate treatment were oversimplified. Interstitial cystitis remains a diagnosis of exclusion.

Citing Articles

Excluding confusable diseases in patients with presumptive diagnosis of interstitial cystitis: A large patient cohort study.

Jeong H, Kang Y, Choo M, Jeong S, Oh S Int J Gynaecol Obstet. 2024; 168(1):369-376.

PMID: 39127911 PMC: 11649886. DOI: 10.1002/ijgo.15856.


Risk of Urinary Tract Carcinoma among Subjects with Bladder Pain Syndrome/Interstitial Cystitis: A Nationwide Population-Based Study.

Wu M, Luo H, Weng S, Ho C, Chancellor M, Chuang Y Biomed Res Int. 2018; 2018:7495081.

PMID: 30050942 PMC: 6046152. DOI: 10.1155/2018/7495081.


CUA guideline: Diagnosis and treatment of interstitial cystitis/bladder pain syndrome.

Cox A, Golda N, Nadeau G, Nickel J, Carr L, Corcos J Can Urol Assoc J. 2016; 10(5-6):E136-E155.

PMID: 27790294 PMC: 5065402. DOI: 10.5489/cuaj.3786.


Clinical presentation and treatment of bladder pain syndrome/interstitial cystitis (BPS/IC) in India.

Mishra N Transl Androl Urol. 2016; 4(5):512-23.

PMID: 26816851 PMC: 4708552. DOI: 10.3978/j.issn.2223-4683.2015.10.05.


Painful bladder syndrome: an update and review of current management strategies.

Dyer A, Twiss C Curr Urol Rep. 2014; 15(2):384.

PMID: 24384999 DOI: 10.1007/s11934-013-0384-z.